NLRP3 and bronchiectasis: In summary, this study identifies a novel mechanism driving increased airway inflammation in bronchiectasis and calls for a comprehensive strategy to counteract both NLRP3 inflammasome activation and NET formation to manage neutrophilic inflammation, thereby providing new therapeutic targets for the pathogenesis of bronchiectasis.